Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,121.54
(
-0.73%
)
US TECH 100
26,188.00
(
-1.43%
)
Dow Jones
49,234.59
(
-0.15%
)
Brent Oil
104.33
(
2.17%
)
Bitcoin
75,988.36
(
-1.79%
)
News Focus
News Focus
Post# of 257454
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Wednesday, 10/03/2012 9:07:29 AM

Wednesday, October 03, 2012 9:07:29 AM

Post# of 257454
Celgene (CELG) and privately held VentiRx sign a deal to develop the latter's VTX-2337 compound for the treatment of cancer. Under the agreement, Celgene will pay $35M for further R&D, and will retain the option to make an equity investment in VentiRx or aquire the company
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today